An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses
RSC Medicinal Chemistry · 2026 · 17 (1) · 396-410
DOI: 10.1039/d5md00709g ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Huda R M Rashdan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 1…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Neglected tropical diseases (NTDs) encompass a broad spectrum of infectious diseases predominantly found in tropical and subtropical regions.
Autor:innen und Institutionen
- Chemistry of Natural and Microbial Products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University Alexandria 21521 Egypt.
- Pharmacy Program, Allied Health Department, College of Health and Sport Sciences, University of Bahrain P.O. Box 32038 Bahrain.
- Faculty of Chemistry and Chemical Engineering, University of Maribor Smetanova 17 SI-2000 Maribor Slovenia.
- Laboratory of Pharmacology & Pharmacotherapeutics, College of Pharmaceutical Sciences, Ritsumeikan University Kusatsu Shiga Japan.
- Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt sabt.nrc@gmail.com.
ORCID-Profile: Huda R M Rashdan, Abdelsamed I Elshamy, Tamer M Ibrahim, Wagdy M Eldehna, Ahmed Sabt
Zitieren
APA
Rashdan, H. R. M., Bekhit, A. A., Furlan, V., Amagase, K., Elshamy, A. I., Elfar, N., Abdo, M. R., Ibrahim, T. M., Bren, U., Eldehna, W. M., & Sabt, A. (2026). An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses. RSC Medicinal Chemistry, 17(1), 396-410. https://doi.org/10.1039/d5md00709g
Vancouver
Rashdan HRM, Bekhit AA, Furlan V, Amagase K, Elshamy AI, Elfar N, et al. An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses. RSC Medicinal Chemistry. 2026;17(1):396-410. doi:10.1039/d5md00709g
BibTeX
@article{Rashdan2026,
author = {Rashdan, Huda R M and Bekhit, Adnan A and Furlan, Veronika and Amagase, Kikuko and Elshamy, Abdelsamed I and Elfar, Nourhan and Abdo, Mohamed R and Ibrahim, Tamer M and Bren, Urban and Eldehna, Wagdy M and Sabt, Ahmed},
title = {An exploration of potent antileishmanial agents derived from quinoline–thiazole and thiadiazole hybrids, targeting DHFR-TS and PTR1: design, synthesis, and computational analyses},
journal = {RSC Medicinal Chemistry},
year = {2026},
volume = {17},
number = {1},
pages = {396--410},
doi = {10.1039/d5md00709g}
}
EUVIMED